2293 — Bamboos Health Care Holdings Cashflow Statement
0.000.00%
- HK$221.35m
- HK$230.53m
- HK$74.40m
Annual cashflow statement for Bamboos Health Care Holdings, fiscal year end - June 30th, HKD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | — |
Source: | ARS | ARS | ARS | ARS | |
Standards: | HKAS | HKAS | HKAS | HKAS | — |
Status: | Final | Final | Final | Final | fx Preliminary |
Net Income/Starting Line | 73.5 | 72.4 | 58.7 | 39.2 | — |
Depreciation | |||||
Non-Cash Items | 2.55 | 1.82 | 0.553 | 3.77 | — |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -30.9 | 34.2 | -27.3 | -15.7 | — |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 49.4 | 116 | 41.9 | 37.4 | — |
Capital Expenditures | -0.022 | -186 | -0.261 | -1.66 | — |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -71.4 | 74.7 | 7.18 | -5.43 | — |
Acquisition of Business | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -71.4 | -112 | 6.92 | -7.09 | — |
Financing Cash Flow Items | -0.002 | -0.679 | -1.81 | -2.73 | — |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -23 | 25.1 | -41.8 | -42.4 | — |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -45 | 29.6 | 7 | -12.1 | — |